Patients with decreased kidney function have increased risks for hypoglycemia for 2 reasons: (1) decreased clearance of insulin and some of the oral agents used to treat diabetes[11, 12], and (2) impaired kidney gluconeogenesis.[12] It is not known whether different DM treatment agents would bring different outcomes in patients with end stage renal disease (ESRD). Here, INS is linked to diabetes mellitus.